scispace - formally typeset
M

Miranda Thomas

Researcher at International Centre for Genetic Engineering and Biotechnology

Publications -  67
Citations -  6099

Miranda Thomas is an academic researcher from International Centre for Genetic Engineering and Biotechnology. The author has contributed to research in topics: PDZ domain & Ubiquitin. The author has an hindex of 33, co-authored 63 publications receiving 5723 citations. Previous affiliations of Miranda Thomas include AREA Science Park.

Papers
More filters
Journal ArticleDOI

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.

TL;DR: Allelic analysis of patients with HPV-associated tumours revealed a striking overrepresentation of homozygous arginine-72 p53 compared with the normal population, which indicated that individuals homozygously for arginin 72 are about seven times more susceptible to HPV- associated tumorigenesis than heterozygotes.
Journal ArticleDOI

Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically

TL;DR: Both p53Arg and p53Pro are morphologically wild type and do not differ in their ability to bind to DNA in a sequence-specific manner, however, there are a number of differences between the p53 variants in their abilities to bind components of the transcriptional machinery, to activate transcription, to induce apoptosis, and to repress the transformation of primary cells.
Journal ArticleDOI

The role of the E6-p53 interaction in the molecular pathogenesis of HPV.

TL;DR: Like all viral oncoproteins, E6 is a multifunctional protein and a plethora of other cellular targets has been identified, and E6's interactions with some of these additional targets appear to be equally important in the pathogenesis of HPV, and may also represent valid targets for therapeutic intervention.
Journal ArticleDOI

Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins

TL;DR: Evidence is presented that Bak protein is involved in signaling apoptosis in the skin in response to UVB damage, and that cutaneous HPV E6 proteins target and abrogate Bak function by promoting its proteolytic degradation both in vitro and in regenerated epithelium.
Journal ArticleDOI

Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins.

TL;DR: The findings indicate that MAGI-1 is a member of a select group of cellular PDZ proteins targeted by both adenovirus E4-ORF1 and high-risk HPV E6 proteins and suggest that the tumorigenic potentials of these viral oncoproteins depend, in part, on an ability to inhibit the function of MAGi-1 in cells.